JM

Jennifer Macdiarmid

Joint-CEO and Director

EnGeneIC

Sydney, New South Wales


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
EnGeneIC
Industry
research
Employees
42.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
23022691.0
Latest Funding
Equity Crowdfunding

Technologies

Outlook GoDaddy Hosting Android Basis Remote AI

Keywords

biotechnology cancer therapeutics bioprocessing nanotechnology biotechnology research biopharmaceutical targeted therapies anti-cancer immunotherapy edv nanocell drug delivery clinical trials chemo drugs covid-19 vaccine immune response patent portfolio therapeutic efficacy recurrent glioblastoma mesothelioma treatment vaccine development cancer research trial protocols biotech innovation antibody stimulation tumor targeting viral vaccines patient safety clinical efficacy customized oncology functional nucleic acids immune system activation minicell technology fda fast-track designation biological agents tumor microenvironment peptide delivery cytotoxic treatment gene therapy cellular therapies oncology solutions vaccine design nanoparticle delivery high-affinity antibodies clinical approval patient recruitment biotechnology sector drug resistance therapeutic developments research collaboration molecular targeting cancer biomarkers drug conjugates antigen-specific therapies health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans